ANTIHYPERTENSIVE EFFICACY OF FIXED COMBINATION AZILSARTAN MEDOXOMIL/CHLORTHALIDONE IN PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION

被引:0
|
作者
Kobalava, Zh. D. [1 ]
Villevalde, S. V. [1 ]
Kulakov, V. V. [1 ]
机构
[1] RUDN Univ, Peoples Friendship Univ Russia, Moscow, Russia
关键词
azilsartan medoxomil; chlorthalidone; ambulatory blood pressure monitoring; efficacy; safety; BLOOD-PRESSURE; MEDOXOMIL; CHLORTHALIDONE; HYDROCHLOROTHIAZIDE; MANAGEMENT; VALSARTAN;
D O I
10.10087/cardio.2017.11.10049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study effects of a fixed azilsartan medoxomil/chlorthalidone combination (Edarbi Clo) on clinical, ambulatory and central blood pressure (BP) in patients with uncontrolled arterial hypertension (AH)). Materials and methods. Patients (n=25) with uncontrolled AH were given fixed azilsartan medoxomil/chlorthalidone combination (40/12.5 mg/day) for 4 weeks. After 4 weeks, in patients who did not achieve target BP levels the dose was increased up to 40/25 mg/day. Duration of the study was 12 weeks. Results. After 12 weeks of treatment 88% of patients achieved target clinical BP (< 140/90 mm Hg without diabetes, < 140/85 mm Hg with diabetes). According to 24-hour blood pressure monitoring (ABPM) decline of mean BP was 19.3/11.1 mm Hg, of mean daytime peripheral BP - 20.1/11.4 mm Hg, of mean nocturnal peripheral BP - 19.5/9.1 mm Hg, of central systolic (S), diastolic and pulse BP - 15.8, 10.1, 6.6 mm Hg, respectively. Target values of mean 24-hour BP were achieved in 40% of patients. Improvement of ABPM parameters led to normalization of the daily systolic BP index, associated with increase of the portion of "dippers" (from 60 to 64%) and reduction of that of "night-pickers" at the account of their transition into "non-dipper" and "dipper" categories. There were no adverse events either causing discontinuation after the first dose or serious. Conclusion. In patients with uncontrolled AP with/without diabetes therapy with fixed- azilsartan medoxomil/chlorthalidone combination was accompanied by pronounced antihypertensive effect (lowering of clinical, daily peripheral BP, improvement of the daily SBP profile). For the first time, the effectiveness of azilsartan medoxomil/chlorthalidone combination was demonstrated in relation to the central systolic, diastolic and pulse BP. Significant changes of parameters of carbohydrate or lipid metabolism, adverse events leading to drug discontinuation were not registered.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [41] Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
    Juhasz A.
    Wu J.
    Hisada M.
    Tsukada T.
    Jeong M.H.
    Clinical Hypertension, 24 (1)
  • [42] QUALITY OF LIFE AND EMOTIONAL IMPACT OF A FIXED DOSE COMBINATION OF ANTIHYPERTENSIVE DRUGS IN PATIENTS WITH UNCONTROLLED HYPERTENSION
    Schmieder, R. E.
    Fronk, E.
    Alexandre, A. F.
    Bramlage, P.
    VALUE IN HEALTH, 2015, 18 (07) : A397 - A397
  • [43] COMPARISON OF ANTIHYPERTENSIVE EFFICACY OF THE NEW ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL WITH RAMIPRIL
    Boenner, G.
    Bakris, G. L.
    Sica, D.
    Weber, M.
    White, W. B.
    Perez, A.
    Cao, C.
    Kupfer, S.
    JOURNAL OF HYPERTENSION, 2010, 28 : E283 - E283
  • [44] EFFECTS OF FIXED DOSE COMBINATION AZILSARTAN MEDOXOMIL/CHLORTALIDONE ON THE CENTRAL BP IN HYPERTENSIVE PATIENTS WITH HFPEF
    Gudieva, Khyadi
    Medovschikov, Vadim
    Eshniyazov, Nurlan
    Kravchenko, Alina
    Safarova, Ayten
    Kobalava, Zhanna
    JOURNAL OF HYPERTENSION, 2021, 39 : E373 - E373
  • [45] Clinical Efficacy of Combined Use of Azilsartan with Indapamide and Azilsartan with Nitrendipine in Patients with Arterial Hypertension
    Mashkurova, Z. T.
    Abdullaeva, G. Zh
    Khamidullaeva, G. A.
    Sherbadalova, N. Kh
    Khatamova, M. N.
    Safarov, Zh. B.
    Atoeva, M. I.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2022, 12 (03) : 367 - 374
  • [46] Comparative study of efficacy of treatment of patients with mild arterial hypertension by atenolol and combination of atenolol chlorthalidone
    Petunin, SN
    Merkulova, NK
    Bondarenko, BB
    Shurygina, VD
    KARDIOLOGIYA, 1997, 37 (01) : 70 - 70
  • [47] ANTIHYPERTENSIVE EFFICACY OF SLOW-RELEASE METOPROLOL AND CHLORTHALIDONE AS FIXED COMBINATION - A RANDOMIZED DOUBLE-BLIND COMPARISON WITH CHLORTHALIDONE
    DESSIFULGHERI, P
    GLORIOSO, N
    MADEDDU, P
    OPPES, M
    MANCA, G
    VERDECCHIA, P
    MOTOLESE, M
    RAPPELLI, A
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1983, 34 (03): : 515 - 522
  • [48] Antihypertensive effect of a fixed-dose combination of losartan /hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study
    Hosoya, Tatsuo
    Kuriyama, Satoru
    Ohno, Iwao
    Kawamura, Tetsuya
    Ogura, Makoto
    Ikeda, Masato
    Ishikawa, Masahiro
    Hayashi, Fumihiro
    Kanai, Tatsuya
    Tomonari, Haruo
    Soejima, Michimasa
    Akaba, Kiyoaki
    Tokudome, Goro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (02) : 269 - 278
  • [49] Quality of life and emotional impact of a fixed-dose combination of antihypertensive drugs in patients with uncontrolled hypertension
    Schmieder, Roland E.
    Jumar, Agnes
    Fronk, Eva-Maria
    Alexandre, Ana-Filipa
    Bramlage, Peter
    JOURNAL OF CLINICAL HYPERTENSION, 2017, 19 (02): : 126 - 134
  • [50] Antihypertensive effect of a fixed-dose combination of losartan /hydrochlorothiazide in patients with uncontrolled hypertension: a multicenter study
    Tatsuo Hosoya
    Satoru Kuriyama
    Iwao Ohno
    Tetsuya Kawamura
    Makoto Ogura
    Masato Ikeda
    Masahiro Ishikawa
    Fumihiro Hayashi
    Tatsuya Kanai
    Haruo Tomonari
    Michimasa Soejima
    Kiyoaki Akaba
    Goro Tokudome
    Clinical and Experimental Nephrology, 2012, 16 : 269 - 278